anti pi3k antibody (Proteintech)
Proteintech is a verified supplier 
96
Structured Review
Proteintech
anti pi3k antibody
Anti Pi3k Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 317 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+pi3k/PI3K+p85+alpha+Antibody/pmc13620287-191-75-77
Average 96 stars, based on 317 article reviews
Anti Pi3k Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 317 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+pi3k/PI3K+p85+alpha+Antibody/pmc13620287-191-75-77
Average 96 stars, based on 317 article reviews
anti pi3k antibody - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Incubation:Article Title: TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma. Article Snippet: .. Membranes were blocked with 5% nonfat milk for 1 h at room temperature and incubated overnight at 4 ° C with the following primary antibodies: anti-FBL (Proteintech, Cat# 66985-1-Ig), anti-Trim21 (Proteintech, Cat# 12108-1-AP), Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 min at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731-1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), anti-BCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Article Title: TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma Article Snippet: .. Membranes were blocked with 5% nonfat milk for 1 h at room temperature and incubated overnight at 4 °C with the following primary antibodies: anti-FBL (Proteintech, Cat# 66985-1-Ig), anti-Trim21 (Proteintech, Cat# 12108-1-AP), Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway. Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 minutes at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731- 1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), antiBCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Western Blot:Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 min at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731-1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), anti-BCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway. Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 minutes at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731- 1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), antiBCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Blocking Assay:Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 min at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731-1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), anti-BCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway. Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 minutes at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731- 1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), antiBCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), |
